|
SRRD expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.094100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.372400E-01 |
| Normal-vs-Stage2 |
4.120600E-01 |
| Normal-vs-Stage3 |
3.953800E-01 |
| Normal-vs-Stage4 |
6.879000E-03 |
| Stage1-vs-Stage2 |
9.991200E-01 |
| Stage1-vs-Stage3 |
8.774800E-01 |
| Stage1-vs-Stage4 |
5.318300E-02 |
| Stage2-vs-Stage3 |
9.202800E-01 |
| Stage2-vs-Stage4 |
1.727200E-01 |
| Stage3-vs-Stage4 |
9.817800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.450000E-02 |
| Normal-vs-AfricanAmerican |
9.666500E-02 |
| Normal-vs-Asian |
6.245000E-01 |
| Caucasian-vs-AfricanAmerican |
6.044700E-04 |
| Caucasian-vs-Asian |
9.381200E-01 |
| AfricanAmerican-vs-Asian |
1.739980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.796500E-02 |
| Normal-vs-Female |
1.360850E-01 |
| Male-vs-Female |
8.240200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.834200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.514100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.156200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.538600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.779600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.024600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.125400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.112600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.044400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.594200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.394600E-01 |
| Normal-vs-Grade 2 |
1.482360E-01 |
| Normal-vs-Grade 3 |
1.338770E-01 |
| Normal-vs-Grade 4 |
8.044400E-02 |
| Grade 1-vs-Grade 2 |
9.824200E-01 |
| Grade 1-vs-Grade 3 |
9.617000E-01 |
| Grade 1-vs-Grade 4 |
5.117800E-01 |
| Grade 2-vs-Grade 3 |
8.395000E-01 |
| Grade 2-vs-Grade 4 |
3.221200E-01 |
| Grade 3-vs-Grade 4 |
3.968800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.303590E-01 |
| Normal-vs-ccB subtype |
1.034180E-02 |
| ccA subtype-vs-ccB subtype |
1.224150E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.916100E-02 |
| Normal-vs-N1 |
4.358200E-01 |
| N0-vs-N1 |
8.422200E-01 |
|
|
